Medication Adherence in Patients with Rheumatoid Arthritis and Disease-related Complications: A Cross-sectional Study from a North Indian Tertiary Care Centre

Background: Medication non-adherence to disease-modifying antirheumatic drugs (DMARDs) remains a major barrier to optimal rheumatoid arthritis (RA) management, particularly in low- and middle-income countries. This study assessed medication adherence among RA patients with disease-related complications and examined its association with clinical characteristics. Methods: A cross-sectional study was conducted between August 2024 and August 2025 at a tertiary care hospital in New Delhi, India. Adults with RA fulfilling the 2010 ACR/EULAR classification criteria, receiving DMARD therapy, and having at least one pre-defined RA-related complication were enrolled. Medication adherence was assessed using the 19-item Compliance Questionnaire for Rheumatology (CQR-19), with scores ≥80 indicating high adherence. Clinical and demographic variables, including disease activity, joint deformities, extra-articular manifestations, and DMARD regimen, were analysed for associations with adherence. Results: Thirty patients were included, of whom 80% were women. Nineteen patients (63.3%) demonstrated poor medication adherence. Anaemia was the most common complication (66.7%), followed by joint deformities (53.3%). Poor adherence was significantly associated with the presence of joint deformities (81.3% vs. 42.9%, P = .029) and an increasing number of prescribed DMARDs ( P = .020). No significant associations were observed between adherence and disease activity (CDAI or DAS28-ESR), disease duration, educational status or anaemia. Conclusion: Medication non-adherence is highly prevalent among patients with RA and disease-related complications. Poor adherence is significantly associated with joint deformities and increasing treatment complexity, highlighting the need for early adherence assessment, patient counselling and strategies to simplify treatment regimens to improve long-term clinical outcomes.

Authors

Institutions

Publication Details

Journal
Indian Journal of Rheumatology
Published
2026-11-18
DOI
https://doi.org/10.1177/09733698261503001
Primary Topic
Medication Adherence and Compliance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Medication Adherence in Patients with Rheumatoid Arthritis and Disease-related Complications: A Cross-sectional Study from a North Indian Tertiary Care Centre

Ghanshyam Pangtey, Danveer Bhadu, Anmol Kaur, Simar Saluja et al.
Indian Journal of Rheumatology
Medication Adherence and Compliance
article

Medication Adherence in Patients with Rheumatoid Arthritis and Disease-related Complications: A Cross-sectional Study from a North Indian Tertiary Care Centre

Ghanshyam Pangtey, Danveer Bhadu, Anmol Kaur, Simar Saluja, Sameer Gulati
article en

Abstract

Background: Medication non-adherence to disease-modifying antirheumatic drugs (DMARDs) remains a major barrier to optimal rheumatoid arthritis (RA) management, particularly in low- and middle-income countries. This study assessed medication adherence among RA patients with disease-related complications and examined its association with clinical characteristics. Methods: A cross-sectional study was conducted between August 2024 and August 2025 at a tertiary care hospital in New Delhi, India. Adults with RA fulfilling the 2010 ACR/EULAR classification criteria, receiving DMARD therapy, and having at least one pre-defined RA-related complication were enrolled. Medication adherence was assessed using the 19-item Compliance Questionnaire for Rheumatology (CQR-19), with scores ≥80 indicating high adherence. Clinical and demographic variables, including disease activity, joint deformities, extra-articular manifestations, and DMARD regimen, were analysed for associations with adherence. Results: Thirty patients were included, of whom 80% were women. Nineteen patients (63.3%) demonstrated poor medication adherence. Anaemia was the most common complication (66.7%), followed by joint deformities (53.3%). Poor adherence was significantly associated with the presence of joint deformities (81.3% vs. 42.9%, P = .029) and an increasing number of prescribed DMARDs ( P = .020). No significant associations were observed between adherence and disease activity (CDAI or DAS28-ESR), disease duration, educational status or anaemia. Conclusion: Medication non-adherence is highly prevalent among patients with RA and disease-related complications. Poor adherence is significantly associated with joint deformities and increasing treatment complexity, highlighting the need for early adherence assessment, patient counselling and strategies to simplify treatment regimens to improve long-term clinical outcomes.

Indian Journal of Rheumatology
Lady Hardinge Medical College (IN), All India Institute of Medical Sciences (IN)
Medication Adherence and Compliance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon